M2 type, represented by markers such as CD206, CD163, IL-10, TGF-β, CCL17, CCL18, CCL22, and Arg-1, mainly inhibits immune inflammatory responses and promotes tumor progression [22]. Here, TGFB1 is linked to neoplasm.